CLOV vs NEUP · rev $1.37B vs rev $15.0M
Clover Health Investments Corp (CLOV) versus Neuphoria Therapeutics Inc (NEUP) — a side-by-side from cached financials, not a winner call.
Clover Health Investments Corp (CLOV) is a healthcare plans company listed on US.
Neuphoria Therapeutics Inc (NEUP) is a biotechnology company listed on NASDAQ.
Latest reported CLOV revenue for 2024-12-31 was $1.37B. Net income was -$43.0M. Revenue was up 8.8% from 2023-12-31 to 2024-12-31. CLOV currently screens at market cap $1.55B.
Latest reported NEUP revenue for 2025-03-31 was $15.0M. Net income was $11.3M. NEUP currently screens at market cap $23.6M.
CLOV currently screens at market cap $1.55B. NEUP currently screens at market cap $23.6M.
Not investment advice. Open the CLOV and NEUP stock pages for the full models.
Not investment advice.